From Normal to Zero Flow in 30 Seconds on HeartMate 3 LVAD: What Happened?

Area of Science:

• Cardiovascular Surgery
• Biomedical Engineering
• Medical Device Technology

Background:

• Left ventricular assist devices (LVADs) are crucial for end-stage heart failure management.
• The HeartMate 3 (HM3) is a leading durable LVAD for de novo implantation in the US.
• Understanding LVAD complications is vital for patient outcomes.

Observation:

• A patient with an HM3 LVAD experienced an acute, unheralded zero flow alarm.
• The patient progressed to cardiac arrest and did not survive.
• Autopsy attributed death to chronic heart failure, but LVAD analysis revealed impeller clot ingestion.

Findings:

• Impeller clot ingestion in an HM3 LVAD occurred without preceding warning signs or altered pump parameters.
• The zero flow alarm was the sole indicator of this critical event.
• This case highlights a rare but severe complication of HM3 LVADs.

Implications:

• The true incidence of pump thrombosis and thrombus ingestion with HM3 LVADs requires further investigation.
• Developing strategies to detect and manage such complications is essential.
• Enhanced understanding is needed to ensure the safety and efficacy of durable LVADs.